Stock Forecast

  Outset Medical, Inc. ( OM) Stock. Should you Buy or Sell?    $ 18.74

0.85 (4.34 %)



Outset Medical, Inc. Analysis

Updated on 10-09-2022
Symbol OM
Price $18.74
Beta 0.000
Volume Avg. $726.96 thousand
Market Cap $899.66 M
52 Week Range $13.25 - $60.33


Outset Medical, Inc. opened the day at $18.74 which is +'4.34 % on yesterday's close. Outset Medical, Inc. has a 52 week high of $60.33 and 52 week low of $13.25, which is a difference of $47.08. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $899.66 M and total net profit is $102602000 which means the company is trading at 8.77 times profit to market capitalization. Theoretically, if you were to buy Outset Medical, Inc. for $899.66 M, it would take 15 years to get your money back. Outset Medical, Inc. are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




Outset Medical, Inc. Stock Forecast - Is Outset Medical, Inc. a Buy or Sell?


DCF ScoreStrong Buy
ROE ScoreSell
ROA ScoreSell
DE ScoreNeutral
PE ScoreStrong Sell
PB ScoreStrong Buy
Overall RecommendationNeutral

Growth and Value


PE Ratio -5.887
Dividend Yiel 0.000
Net Profit Margin -1.385


Valuing Outset Medical, Inc.


Price Book Value Ratio 2.897 Price To Book Ratio 2.897
Price To Sales Ratio 8.152 Price Earnings Ratio -5.887


How liquid is Outset Medical, Inc.


Current Ratio 6.260
Quick Ratio 5.190


Debt


Debt Ratio 0.228 Debt Equity Ratio 0.295
Long Term Debt To Capitalization 0.102 Total Debt To Capitalization 0.107



Latest news about Outset Medical, Inc.


Outset Medical to Present at the 20th Annual Morgan Stanley Global Healthcare Conference

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2022 at 11:55am PT / 2:55pm ET. A live and archived webcast of the fireside chat will be available on the “Investors” section of the

Date : 30/08/2022

Outset Medical, Inc. (OM) CEO Leslie Trigg on Q2 2022 Results - Earnings Call Transcript

Outset Medical, Inc. (NASDAQ:OM ) Q2 2022 Earnings Conference Call August 1, 2022 5:00 PM ET Company Participants Jim Mazzola - Vice President Investor Relations Leslie Trigg - Chair & Chief Executive Officer Nabeel Ahmed - Chief Financial Officers Conference Call Participants Travis Steed - Bank of America Josh Jennings - Cowen Suraj Kalia - Oppenheimer Rick Wise - Stifel Phil Coover - Goldman Sachs Drew Ranieri - Morgan Stanley Josh Jennings - Cowen Operator Greetings, and welcome to Outset Medical Q2 2022 Earnings Conference Call. At this time, all participants are in listen-only mode.

Date : 05/08/2022

Outset Medical Stock Is Soaring: Here's Why Even Bigger Gains Could Be Ahead

A major FDA decision clears the way for Outset to again go after a huge opportunity.

Date : 02/08/2022

Outset Medical, Inc. (OM) Reports Q2 Loss, Misses Revenue Estimates

Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -22.22% and 2.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Date : 01/08/2022

Does Outset Medical, Inc. (OM) Have the Potential to Rally 94% as Wall Street Analysts Expect?

The mean of analysts' price targets for Outset Medical, Inc. (OM) points to a 93.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Date : 13/07/2022





About Outset Medical, Inc.


CEO : Ms. Leslie L. Trigg
Sector : Healthcare
Industry : Medical Devices

Website : https://www.outsetmedical.com

Exchange : NASDAQ Global Select

Description :

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.


My Newsletter

Sign Up For Updates & Newsletters